Coala Life is a Swedish medical technology and life science company that focuses on heart diagnostics and digital health. The company has developed a portfolio of solutions based on the Coala, a patented and commercial service for remote monitoring and self-screening of heart sounds and ECG. The Coala is available direct to consumers and the Coala Pro is offered to healthcare professionals to enable smart, digital cardiac assessments.

Corrie is an evidenced-based digital health program that has been evaluated in the Myocardial Infarction, COmbined-device, Recovery Enhancement MiCORE Study (ClinicalTrials.gov Identifier: NCT03760796) at 4 hospitals and was shown to reduce risk of 30-day readmission, improve patient experience, and create cost-savings. Corrie is a prescription strength virtual care program that consists of a smartphone application paired with a smartwatch and bluetooth blood pressure cuff. Key features of Corrie include 1) tracking and reminders for cardiac medications; 2) monitoring BP with an Food and Drug Administration–approved wireless BP cuff; 3) promoting exercise, physical activity, step tracking, via a smartwatch 4) providing peer-reviewed educational videos and articles on diet, medications, and how to prevent CVD/hypertension/dyslipidemia/glucose intolerance through lifestyle modification; 5) reviewing patient reported data through a check-up feature that allows patients to send health summary reports of physical activity and vitals to clinicians; and 6) connecting with providers and addressing social determinants of health services to optimize guideline-directed evidence-based care. In the era of COVID-19 and beyond the Corrie program is a technology-enhanced patient experience that provides the fundamental care components, data collection, and support for optimal cardiac recovery.

Helping to solve one of the largest problems facing global healthcare, we are fortunate to have a Johns Hopkins team that has been intensively working in digital health technology and leading the world in its development, evaluation, and integration with healthcare delivery. The Corrie Health® Platform is the culmination of 4 years of cross-university teamwork and research at Johns Hopkins to improve evidenced-based care at Johns Hopkins and across the country. Corrie (“Cor” is Latin for heart) was created by an interdisciplinary team of Johns Hopkins cardiologists, internists, nurses, engineers, Armstrong patient safety and quality improvement leaders, and behavioral health specialists, in partnership with Apple designers and patients to improve cardiovascular prevention. Corrie’s intuitive user interface was built in close collaboration with engineers and designers at Apple to empower patients in self-management, and is now available on Android as well. At its core, the Corrie Health® Digital Platform is a smartphone application driving self-management of medications, vitals, activity, and care coordination connected to cooperative sensors including a smartwatch and wireless blood pressure cuff. The Corrie Cloud securely stores data metrics and vitals from the app to make them accessible within the upcoming Corrie Portal where real-time data analysis is performed to detect digital biomarkers and activate external actions via the Corrie Decision Engine. This will trigger near real-time alerts on Corrie Care for providers, care companions, and pharmacists so they can respond in a timely fashion to risk signals detected from changes in the patient’s clinical status. Corrie Health® is the intersection of enhanced patient engagement, data analytics targeting digital biomarkers, and remote monitoring working together to reduce hospital readmissions and promote personalized, cost-effective care. The Corrie Care app and the Corrie Portal will initially be available as a technology preview and grow in features as we continue to gather feedback. Corrie Health® offers major value to Hospitals by providing a clinically validated digital health platform deployed in the acute care setting. The Corrie Myocardial infarction, COmbined-device, Recovery Enhancement (MiCORE) Study examined whether using the Corrie Health Digital Platform could reduce all-cause, unplanned 30-day hospital readmissions and related healthcare costs for acute myocardial infarction (AMI) patients as compared to a historical comparison group. The study was carried out at two leading academic hospitals, Massachusetts General and Johns Hopkins, and two community hospitals, Reading Health System and Johns Hopkins Bayview Medical Center. Corrie was the intervention in the study that served as a self-management digital health program to support guideline-directed care including: 1) medication adherence, 2) vitals monitoring, 3) peer-reviewed education, 4) physical activity, 5) follow-up appointment tracking, and 6) connection with clinicians. From October 1, 2016 to April 14, 2019, 200 English-speaking adults diagnosed with Type I AMI who owned a smartphone were enrolled across four hospitals in the United States. Patients received Corrie as early as possible in their hospitalization and were encouraged to use it during the hospitalization through 30 days post-hospital discharge. The historical comparison group consisted of 864 adults who were admitted between October 2015-2016 with STEMI or NSTEMI from these study hospitals. The final results are under review but showed: ● Major reduction in risk of 30-day all cause readmission compared to the historical control group ● Significant cost savings per patient compared to standard of care alone for a hospital and increased quality of life years. [Based on the assumption that Corrie costs $3,000 per patient. Cost savings is per hospital based on savings from readmission reduction] ● Majority of Corrie users felt confident managing medications, follow-up appointments, and home care at 30 days